|
Synthesis of N-Nitroso Finerenone
|
|
1
|
120
|
April 7, 2025
|
|
:brazil: Lhasa Brazil Symposium: Aligning Pharma & Regulatory Standards Globally :brazil:
|
|
0
|
105
|
April 3, 2025
|
|
Nitrosamine in Rizatriptan Benzoate
|
|
4
|
227
|
April 3, 2025
|
|
N-Nitroso clozapine
|
|
2
|
178
|
April 3, 2025
|
|
Laboratory Study in Gastric Nitrosamine Formation
|
|
8
|
363
|
April 2, 2025
|
|
Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential -Pub
|
|
8
|
497
|
April 2, 2025
|
|
Analysis of Nitrosamines in Water-Insoluble APIs by LC-MS/MS
|
|
1
|
172
|
April 2, 2025
|
|
🇺🇸 FDA Control of Nitrosamine Impurities in Human Drugs revision2
|
|
53
|
3928
|
April 2, 2025
|
|
Health Canada recalled drug products
|
|
0
|
582
|
April 1, 2025
|
|
🇯🇵 Current Nitrosamine Landscape in Japan?
|
|
140
|
12927
|
April 1, 2025
|
|
New publication on "Nitrosation" from MultiCASE
|
|
7
|
469
|
March 29, 2025
|
|
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
|
|
0
|
157
|
March 28, 2025
|
|
Looking for insights on N-nitroso-sertraline analysis by LC-MS
|
|
7
|
306
|
March 28, 2025
|
|
Testing of N-nitroso-cinacalcet
|
|
5
|
388
|
March 27, 2025
|
|
Industrial Case Studies Demonstrating Applicability of ICH M7Control Options 3 and 4 for Nitrosamine Control -Pub
|
|
3
|
454
|
March 26, 2025
|
|
Quantitative Investigation of Nitrosamine Drug Substance-Related Impurities (NDSRIs) Under Artificial Gastric Conditions by Liquid Chromatography–Tandem Mass Spectrometry and Structure–Activity Relationship Analysis -Pub
|
|
0
|
249
|
March 24, 2025
|
|
The quagmire with the interim limit of nitroso duloxetine
|
|
4
|
450
|
March 24, 2025
|
|
N-nitrosodicyclohexylamine (NDCHA), what do you know about it?
|
|
18
|
450
|
March 21, 2025
|
|
Chemistry of N-Nitroso Ivacaftor
|
|
10
|
1229
|
March 21, 2025
|
|
Modified NAP Test: A Simple and Responsive Nitrosating Methodology for Risk Evaluation of NDSRIs -Pub
|
|
5
|
3640
|
March 20, 2025
|
|
Phathom Pharmaceuticals reported nitrosamine impurity in their vonoprazan-based products
|
|
25
|
3093
|
March 20, 2025
|
|
AI limits and CPCA score (O=NN1CCN=C1CCl)
|
|
8
|
338
|
March 17, 2025
|
|
Draft guidance on the use of read across for chemical safety assessment in food and feed(EFSA)
|
|
0
|
178
|
March 16, 2025
|
|
Dr. Andrew Teasdale on the recent updates on Nitrosamine Impurities - Virtual Workshop
|
|
1
|
567
|
March 15, 2025
|
|
Acceptance criteria for Nitrosamines Method Validation
|
|
3
|
328
|
March 14, 2025
|
|
Phenyl Morpholine
|
|
1
|
107
|
March 14, 2025
|
|
NDSRI in finishe products
|
|
2
|
270
|
March 13, 2025
|
|
Analytical procedure development and proposed established conditions: A case study of a mass spectrometry based NDSRI analytical procedure -Pub
|
|
20
|
1898
|
March 12, 2025
|
|
Is there any possibility to generate the N-Desmethyl Tramadol in formulation?
|
|
5
|
431
|
March 11, 2025
|
|
Nitrosamine Calculation in Sita + Met Tablets
|
|
8
|
369
|
March 11, 2025
|